Evogene to transfer stock exchange listing to Nasdaq

Evogene Ltd., a leading company for the improvement of crop productivity and economics for the food, feed and fuel industries, announced today that it will transfer its stock exchange listing to the Nasdaq Global Market (“Nasdaq”) from the New York Stock Exchange (“NYSE”). Evogene’s ordinary shares will continue to trade on the NYSE until the market close on December 29, 2016. The Company expects its ordinary shares will begin trading on Nasdaq on December 30, 2016, and its shares will continue to trade under the ticker symbol “EVGN".

“Nasdaq is home to many of the world’s most innovative companies,” said Ofer Haviv, President and Chief Executive Officer of Evogene. “Evogene’s biological expertise combined with our cutting-edge computational capabilities, positions us as a driving force behind the development of the next-generation of agriculture products, and we are proud to be part of a marketplace that nurtures young, growth oriented companies as we continue to deliver on our long-term vision.”

"We are excited to welcome Evogene to the Nasdaq family. Evogene is a market leader in the field of crop productivity improvement through biotechnology and one of the innovative companies from Israel which is striving to make this world a better place by using cutting edge technology. Nasdaq, home to the world's largest and most innovative companies, is proud to have over 80 Israeli companies listed, making it the country with the second largest number of companies trading on the Nasdaq after the U.S.," said Nelson Griggs, Executive Vice President, Global Listing Services at Nasdaq. "We look forward to working with and supporting Evogene as it grows and achieves new milestones."